Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1977 1
1978 2
1979 1
1980 5
1981 2
1982 4
1983 3
1984 2
1985 1
1986 2
1987 2
1988 3
1989 2
1990 5
1991 5
1992 3
1993 2
1994 4
1995 3
1996 3
1997 3
1998 7
1999 5
2000 12
2001 5
2002 6
2003 8
2004 10
2005 11
2006 12
2007 14
2008 10
2009 10
2010 16
2011 10
2012 18
2013 14
2014 20
2015 18
2016 17
2017 17
2018 19
2019 13
2020 19
2021 14
2022 9
Text availability
Article attribute
Article type
Publication date

Search Results

340 results
Results by year
Filters applied: . Clear all
Page 1
Danger signals and inflammaging in osteoarthritis.
Millerand M, Berenbaum F, Jacques C. Millerand M, et al. Among authors: jacques c. Clin Exp Rheumatol. 2019 Sep-Oct;37 Suppl 120(5):48-56. Epub 2019 Oct 15. Clin Exp Rheumatol. 2019. PMID: 31621566 Free article. Review.
Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma.
Benboubker L, Dimopoulos MA, Dispenzieri A, Catalano J, Belch AR, Cavo M, Pinto A, Weisel K, Ludwig H, Bahlis N, Banos A, Tiab M, Delforge M, Cavenagh J, Geraldes C, Lee JJ, Chen C, Oriol A, de la Rubia J, Qiu L, White DJ, Binder D, Anderson K, Fermand JP, Moreau P, Attal M, Knight R, Chen G, Van Oostendorp J, Jacques C, Ervin-Haynes A, Avet-Loiseau H, Hulin C, Facon T; FIRST Trial Team. Benboubker L, et al. Among authors: jacques c. N Engl J Med. 2014 Sep 4;371(10):906-17. doi: 10.1056/NEJMoa1402551. N Engl J Med. 2014. PMID: 25184863 Free article. Clinical Trial.
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.
Miguel JS, Weisel K, Moreau P, Lacy M, Song K, Delforge M, Karlin L, Goldschmidt H, Banos A, Oriol A, Alegre A, Chen C, Cavo M, Garderet L, Ivanova V, Martinez-Lopez J, Belch A, Palumbo A, Schey S, Sonneveld P, Yu X, Sternas L, Jacques C, Zaki M, Dimopoulos M. Miguel JS, et al. Among authors: jacques c. Lancet Oncol. 2013 Oct;14(11):1055-1066. doi: 10.1016/S1470-2045(13)70380-2. Epub 2013 Sep 3. Lancet Oncol. 2013. PMID: 24007748 Clinical Trial.
New Strategies in Enhancing Spinal Fusion.
Katsuura Y, Shafi K, Jacques C, Virk S, Iyer S, Cunningham M. Katsuura Y, et al. Among authors: jacques c. HSS J. 2020 Jul;16(2):177-182. doi: 10.1007/s11420-020-09749-5. Epub 2020 Feb 2. HSS J. 2020. PMID: 32508545 Free PMC article. Review.
BET bromodomains' functions in bone-related pathologies.
Jacques C, Lavaud M, Georges S, Tesfaye R, Baud'huin M, Lamoureux F, Ory B. Jacques C, et al. Epigenomics. 2020 Jan;12(2):127-144. doi: 10.2217/epi-2019-0172. Epub 2019 Dec 18. Epigenomics. 2020. PMID: 31849242 Review.
Cytokeratins and dermatology.
Jacques C, de Aquino AM, Ramos-e-Silva M. Jacques C, et al. Skinmed. 2005 Nov-Dec;4(6):354-60; quiz 360-1. doi: 10.1111/j.1540-9740.2005.03810.x. Skinmed. 2005. PMID: 16276151 Review.
The danger from within: alarmins in arthritis.
Nefla M, Holzinger D, Berenbaum F, Jacques C. Nefla M, et al. Among authors: jacques c. Nat Rev Rheumatol. 2016 Nov;12(11):669-683. doi: 10.1038/nrrheum.2016.162. Epub 2016 Oct 13. Nat Rev Rheumatol. 2016. PMID: 27733758 Review.
Drought Stress Memory at the Plant Cycle Level: A Review.
Jacques C, Salon C, Barnard RL, Vernoud V, Prudent M. Jacques C, et al. Plants (Basel). 2021 Sep 10;10(9):1873. doi: 10.3390/plants10091873. Plants (Basel). 2021. PMID: 34579406 Free PMC article. Review.
340 results